3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
4
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Large-Cell, Anaplastic
2
Immunoblastic Lymphadenopathy
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Mycosis Fungoides
1
Lymphoma, Follicular
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pembrolizumab
27
Oxaliplatin
24
Paclitaxel
22
Fluorouracil
21
Carboplatin
18
Leucovorin
16
Cisplatin
16
Capecitabine
16
Radiotherapy
15
Nivolumab
12
Drug Therapy
12
Radiation
10
Trastuzumab
9
Surgical Procedures, Operative
8
Immunotherapy
8
Magnetic Resonance Spectroscopy
7
Esophagectomy
7
Blood Specimen Collection
7
Taxes
6
tislelizumab
5
durvalumab
5
Surveys and Questionnaires
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Irinotecan
5
Immune Checkpoint Inhibitors
5
Docetaxel
5
Bevacizumab
5
Ramucirumab
4
Fluorodeoxyglucose F18
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
10-propargyl-10-deazaaminopterin
×
1 year
×
Clear all
No trials found.